In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...
News-Medical.Net on MSN
Targeting microRNA communication reverses pancreatic cancer's immune suppression
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...
Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
Halifax Courier on MSN
Halifax man to run Greenland’s polar ice cap during 14-marathon year for Pancreatic Cancer UK
A man from Halifax will complete at least one marathon or half-marathon each month in 2026, including two on a polar ice cap ...
Exelixis may only have one drug on the market right now, but with phase 3 results for a potential new blockbuster on the ...
Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Jan. 16, 2026 /CNW/ -- Equity Insider News Commentary – The precision medicine sector is undergoing a ...
News-Medical.Net on MSN
CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct.
While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback